Effet antalgique d’une perfusion de bisphosphonates à la phase aiguëd’un tassement vertébral ostéoporotiquechez le sujet âgé
B. Godfrin(Hôpital Rangueil), P. Arlet(Hôpital Rangueil), C. Dingremont(Hôpital Rangueil), Michel Laroche(Hôpital Rangueil), L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), María Jesús Moro Álvarez(Hôpital Rangueil)
Cited by 2
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138